Sort by
Refine Your Search
-
Cardiac Centre. The Epelman Lab is seeking a highly motivated postdoctoral fellow to join our laboratory to study mechanisms of cardiovascular disease using integrative mouse models of multi-morbidity. Our
-
Nature Careers | Vancouver South Shaughnessy NW Oakridge NE Kerrisdale SE Arbutus Ridge, British Columbia | Canada | 2 months ago
currently based on clinical and lifestyle factors, but these have limited predictive value. Adding molecular risk factors to these assessments could improve risk prediction. Our recent research has shown
-
models for neurological diseases (e.g., Multiple Sclerosis) and cancers, applying these modeling advances to patient-level outcome prediction, treatment-response modelling, and the discovery of image-based
-
treatment strategies that can work alongside existing immunomodulatory therapies to treat metastatic disease. We use advanced somatic mouse models of mammary carcinogenesis to model chronic systemic
-
Lab, Montreal Neurological Institute (The Neuro), McGill University https://www.couturierlab.com About the Project The Couturier Lab is seeking an enthusiastic and driven Postdoctoral Fellow to
-
, imaging techniques, and modeling of complex systems have created opportunities for exciting research careers at the interface between the physical/ computational sciences and the biological
-
and to work alongside other research assistants and established academic leaders. Work Plans The work plan for the study is based on the steps needed to create statistical models to identify and address
-
researchers, clinicians, and research associates, from specific underrepresented groups to help them launch their research faculty careers in Canada. Through its two-phase model, which begins with mentored
-
Austauschdienst (DAAD) Referat ST43 Kennedyallee 50 53175 Bonn Germany Helpdesk Please pay attention to the FAQ section of the DAAD website: https://www.daad.de/en/study-and-research-in-germany/scholarships
-
organoid (PTGO) models to test immunotherapy strategies. The ultimate goal is to: 1) identify conserved myeloid phenotypes across tumours; 2) determine which are associated with favourable clinical outcomes